1246203-34-8

1246203-34-8 structure

Name: 4-[4-[2-(difluoromethyl)-4-methoxybenzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]aniline
Chemical Name: 4-[4-[2-(difluoromethyl)-4-methoxybenzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]aniline
CAS Number: 1246203-34-8
Molecular Formula: C₂₂H₂₁F₂N₇O₂
Molecular Weight: 453.445
Create Date: 2017-01-18 04:13:46
Modify Date: 2024-04-02 17:56:20

Name	4-[4-[2-(difluoromethyl)-4-methoxybenzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]aniline
Synonyms	Benzenamine, 4-[4-[2-(difluoromethyl)-4-methoxy-1H-benzimidazol-1-yl]-6-(4-morpholinyl)-1,3,5-triazin-2-yl]- 4-(4-(2-(difluoromethyl)-4-methoxy-1H-benzo[d]imidazol-1-yl)-6-morpholino-1,3,5-triazin-2-yl)aniline 4-(4-(2-(difluoromethyl)-4-methoxy-1H-benzimidazol-1-yl)-6-(4-morpholinyl)-1,3,5-triazin-2-yl)aniline 4-{4-[2-(Difluoromethyl)-4-methoxy-1H-benzimidazol-1-yl]-6-(4-morpholinyl)-1,3,5-triazin-2-yl}aniline

Density	1.5±0.1 g/cm3
Boiling Point	705.5±70.0 °C at 760 mmHg
Molecular Formula	C₂₂H₂₁F₂N₇O₂
Molecular Weight	453.445
Flash Point	380.5±35.7 °C
Exact Mass	453.172485
PSA	104.21000
LogP	2.13
Vapour Pressure	0.0±2.2 mmHg at 25°C
Index of Refraction	1.700

1246203-33-7

~86%

1246203-34-8

Literature: PATHWAY THERAPEUTICS INC.; REWCASTLE, Gordon, William; GIDDENS, Anna, Claire; GAMAGE, Swarnalatha, Akuratiya Patent: WO2012/44641 A1, 2012 ; Location in patent: Page/Page column 46; 82-84 ; WO 2012/044641 A1

380430-49-9

1246203-34-8

Literature: PATHWAY THERAPEUTICS INC.; REWCASTLE, Gordon, William; GIDDENS, Anna, Claire; GAMAGE, Swarnalatha, Akuratiya Patent: WO2012/44641 A1, 2012 ; WO 2012/044641 A1

Precursor 2
1246203-33-7 380430-49-9
DownStream 1
1246203-35-9

56-41-7	108-65-6
56-35-9	64-17-5
67-56-1	108-88-3
141-78-6	1310-73-2
13463-67-7	1333-86-4